Not only does IL-6 reduce serotonin concentrations, but synaptic neuroplasticity is also impaired by interleukin-1β (IL-1β), which is released in vivo, contributing to cognitive impairment [100]. The gene discussed is IL6; the disease is Cognitive impairment.